Mandate

Vinge has advised Active Biotech on private placement

February 03, 2011

Active Biotech AB (publ) (NASDAQ OMX Stockholm) has carried out a private placement of new shares of SEK 375 million directed towards international institutional investors and qualified investors in Sweden.

Vinge acted for Active Biotech. Vinge’s team consisted of Erik Sjöman and Christian Lindhé.

Related

Vinge represents Triton in connection with the sale of Aleris

Vinge has represented Triton in connection with the sale of Aleris to Mehiläinen Group.
May 18, 2026

Vinge advises L5 Navigation in connection with the acquisition of Lundaman Instrument

L5 Navigation Systems AB has acquired the shares in Lundaman Instrument AB. Lundaman develops and supplies weighing systems for wheel loaders and forklift trucks, focusing on the construction, recycling, industrial and materials handling sectors.
May 13, 2026

Vinge advises Aonic in connection with the issuance of subsequent senior secured bonds of EUR 25 million

Vinge has advised Aonic AB (publ) in connection with the issuance of subsequent senior secured bonds of EUR 25 million, and parallel written procedure to increase the bond framework to EUR 150 million.
May 12, 2026